Fund Holdings — DAFNA Capital Management LLC

Total Portfolio Value:
$362.25M
Total Bought:
$30.89M
Total Sold:
$19.30M
Net Transaction:
+$11.59M
Notable People:
Nathan Fischel, Fariba Fischel Ghodsian, Dafna Holdings, L.P.
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Spdr S&p Biotech EtfETF
ST STR SP BIOT
404,505415,505+11,000$32.81M$34.46M9.51%+$1.65M
Stereotaxis, Inc.(STXS)13,680,55413,680,5540$24.08M$29.00M8.01%+$4.92M
Revolution Medicines, Inc.(RVMD)656,176677,176+21,000$23.20M$24.91M6.88%+$1.71M
Blueprint Medicines Corp152,263168,763+16,500$13.48M$21.63M5.97%+$8.16M
Merus Bv461,804398,804-63,000$19.44M$20.98M5.79%+$1.54M
AtriCure, Inc.(ATRC)592,273592,2730$19.11M$19.41M5.36%+$302.1K
Cytokinetics, Incorporated(CYTK)398,100398,1000$16.00M$13.15M3.63%-$2.85M
IDEAYA Biosciences, Inc.(IDYA)589,330619,090+29,760$9.65M$13.01M3.59%+$3.36M
Ishares Nasdaq Biotech IndxETF102,500102,5000$13.11M$12.97M3.58%-$142.5K
Ascendis Pharma A/SADR(ASND)80,39872,677-7,721$12.53M$12.54M3.46%+$13.2K
Xenon Pharmaceuticals Inc.(XENE)273,739287,939+14,200$9.18M$9.01M2.49%-$171.5K
Neurocrine Biosciences, Inc.(NBIX)71,61570,615-1,000$7.92M$8.88M2.45%+$955.0K
Axogen, Inc.(AXGN)680,782741,782+61,000$12.59M$8.05M2.22%-$4.55M
Kalvista Pharmaceuticals Inc752,359581,757-170,602$8.68M$6.58M1.82%-$2.11M
DexCom, Inc.(DXCM)65,55265,5520$4.48M$5.72M1.58%+$1.25M
Day One Biopharmaceuticals I
COM
731,363879,163+147,800$5.80M$5.71M1.58%-$85.1K
Stoke Therapeutics, Inc.(STOK)443,998501,972+57,974$2.95M$5.70M1.57%+$2.74M
Tandem Diabetes Care, Inc.(TNDM)294,208294,2080$5.64M$5.48M1.51%-$153.0K
Arcus Biosciences, Inc.(RCUS)625,126627,626+2,500$4.91M$5.11M1.41%+$201.6K
Syndax Pharmaceuticals, Inc.(SNDX)544,502543,602-900$6.69M$5.09M1.41%-$1.60M
Mineralys Therapeutics, Inc.(MLYS)309,200371,523+62,323$4.91M$5.03M1.39%+$116.6K
Ascendis Pharma A/SNOTE 2 250 4 0(ASND)000$4.71M$5.01M1.38%+$300.0K
UroGen Pharma Ltd.(URGN)492,515349,515-143,000$5.45M$4.79M1.32%-$658.9K
Inogen, Inc.(INGN)458,065605,625+147,560$3.27M$4.26M1.18%+$991.5K
Lakefront Biotherapeutics NVADR(LKFT)130,175130,1750$3.27M$3.64M1.01%+$373.6K
Biohaven Ltd.(BHVN)220,235235,235+15,000$5.29M$3.32M0.92%-$1.98M
Proqr Therapeutics N VSHS EURO
SHS EURO
1,567,5611,567,5610$2.08M$3.20M0.88%+$1.11M
Edgewise Therapeutics, Inc.(EWTX)183,140238,140+55,000$4.03M$3.12M0.86%-$907.1K
Insulet Corporation(PODD)11,9009,900-2,000$3.13M$3.11M0.86%-$14.7K
Immunovant, Inc.(IMVT)169,996191,493+21,497$2.91M$3.06M0.85%+$158.7K
Alkermes plcSHS(ALKS)94,200103,748+9,548$3.11M$2.97M0.82%-$142.3K
Bicara Therapeutics Inc212,001317,001+105,000$2.76M$2.94M0.81%+$182.6K
TELA Bio, Inc.(TELA)1,441,0291,441,0290$1.76M$2.80M0.77%+$1.04M
Kura Oncology, Inc.(KURA)463,368463,3680$3.06M$2.67M0.74%-$384.6K
Denali Therapeutics Inc.(DNLI)127,900168,500+40,600$1.74M$2.36M0.65%+$618.5K
COMPASS Pathways plcADS(CMPS)711,046811,046+100,000$2.03M$2.27M0.63%+$237.3K
Align Technology Inc11,00011,0000$1.75M$2.08M0.57%+$335.2K
BioCryst Pharmaceuticals, Inc.(BCRX)558,255218,255-340,000$4.19M$1.96M0.54%-$2.23M
Astria Therapeutics Inc314,775324,775+10,000$1.68M$1.74M0.48%+$59.9K
Keros Therapeutics, Inc.(KROS)130,316130,3160$1.33M$1.74M0.48%+$411.8K
Viking Therapeutics, Inc.(VKTX)64,51664,5160$1.56M$1.71M0.47%+$151.6K
Accuray Inc1,222,3581,222,3580$2.19M$1.67M0.46%-$513.4K
BrainsWay Ltd.ADS(BWAY)156,533127,151-29,382$1.48M$1.67M0.46%+$189.7K
Allogene Therapeutics Inc1,380,1181,380,1180$2.01M$1.56M0.43%-$455.4K
Lexeo Therapeutics, Inc.(LXEO)378,083378,0830$1.31M$1.52M0.42%+$207.9K
Foghorn Therapeutics Inc.(FHTX)304,752300,452-4,300$1.11M$1.41M0.39%+$299.8K
Iteos Therapeutics Inc213,347140,847-72,500$1.27M$1.40M0.39%+$130.6K
ORIC Pharmaceuticals, Inc.(ORIC)242,000135,271-106,729$1.35M$1.37M0.38%+$22.6K
Compass Therapeutics, Inc.(CMPX)0526,660+526,660$0$1.37M0.38%+$1.37M
Immatics N.V.SHS(IMTX)245,000245,0000$1.10M$1.32M0.36%+$213.2K
Alector Inc912,928912,9280$1.12M$1.28M0.35%+$155.2K
MediWound Ltd.SHS NEW(MDWD)64,47964,4790$1.00M$1.25M0.34%+$248.2K
Structure Therapeutics IncADS59,00059,0000$1.02M$1.22M0.34%+$202.4K
Black Diamond Therapeutics I140,000471,000+331,000$217.0K$1.17M0.32%+$951.1K
Larimar Therapeutics, Inc.(LRMR)371,434371,4340$798.6K$1.07M0.30%+$274.9K
Yarrow Bioscience Inc(YARW)636,103636,1030$1.01M$1.05M0.29%+$44.5K
Gossamer Bio, Inc.(GOSS)907,854849,921-57,933$998.6K$1.05M0.29%+$46.8K
Palvella Therapeutics, Inc.(PVLA)43,34843,3480$1.21M$977.1K0.27%-$236.2K
Autolus Therapeutics plcADS(AUTL)586,667425,616-161,051$909.3K$970.4K0.27%+$61.1K
Century Therapeutics, Inc.(IPSC)1,704,2321,704,2320$811.2K$952.2K0.26%+$140.9K
Neurogene Inc.(NGNE)51,50051,096-404$603.1K$763.9K0.21%+$160.8K
BioNTech SEADS(BNTX)10,5007,000-3,500$956.1K$745.3K0.21%-$210.8K
PolyPid Ltd.(PYPD)291,273207,900-83,373$789.4K$733.9K0.20%-$55.5K
Korro Bio, Inc.(KRRO)47,08657,691+10,605$819.8K$720.6K0.20%-$99.2K
Compugen Ltd.(CGEN)272,402272,4020$397.7K$484.9K0.13%+$87.2K
Aquestive Therapeutics Inc142,000142,0000$411.8K$470.0K0.13%+$58.2K
Bicycle Therapeutics PlcADS80,79964,492-16,307$686.0K$448.2K0.12%-$237.8K
Erasca, Inc.(ERAS)340,000350,000+10,000$465.8K$444.5K0.12%-$21.3K
Adicet Bio Inc600,000540,000-60,000$453.0K$329.4K0.09%-$123.6K
ADC Therapeutics SASHS(ADCT)224,081122,081-102,000$316.0K$327.2K0.09%+$11.2K
Sutro Biopharma, Inc.(STRO)437,079437,0790$284.4K$312.0K0.09%+$27.7K
Nektar Therapeutics(NKTR)010,000+10,000$0$258.4K0.07%+$258.4K
Aprea Therapeutics, Inc.(APRE)137,174137,1740$279.8K$231.8K0.06%-$48.0K
Tessera Defense and Homeland Security Inc.(HLSQ)401,136401,1360$222.9K$180.5K0.05%-$42.4K
PROCEPT BioRobotics Corporation(PRCT)03,000+3,000$0$172.8K0.05%+$172.8K
InflaRx N.V.(IFRX)450,000200,000-250,000$459.0K$158.0K0.04%-$301.0K
2seventy Bio Inc429,2520-429,252$2.12M$0—-$2.12M
ARS Pharmaceuticals, Inc.(SPRY)95,2900-95,290$1.20M$0—-$1.20M
Cardiff Oncology, Inc.(CRDF)150,0000-150,000$471.0K$0—-$471.0K
Lineage Cell Therapeutics, Inc.(LCTX)2,511,3740-2,511,374$1.13M$0—-$1.13M
Nevro Corp38,0000-38,000$221.9K$0—-$221.9K
Regulus Therapeutics Inc847,1760-847,176$1.48M$0—-$1.48M
Sage Therapeutics Inc108,2000-108,200$860.2K$0—-$860.2K
Spero Therapeutics, Inc.(SPRO)125,0000-125,000$90.0K$0—-$90.0K
Taysha Gene Therapies, Inc.(TSHA)522,5000-522,500$726.3K$0—-$726.3K
Tenaya Therapeutics, Inc.(TNYA)47,3190-47,319$27.0K$0—-$27.0K
Page 1 of 1
DAFNA Capital Management LLC — 13F Holdings — Q2 2025 | TickerTrail